FDA-Approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An Updated Landscape
Open accessPublished version of a preprint
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
As artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML)-enabled medical devices are increasingly used in healthcare. In this study, we collected publicly available information on AI/ML-enabled medical devices approved by the FDA in the United States, as of the latest update on 19 October 2023. We performed comprehensive analysis of a total of 691 FDA-approved artificial intelligence and machine learning (AI/ML)-enabled medical devices and offer an in-depth analysis of clearance pathways, approval timeline, regulation type, medical specialty, decision type, recall history, etc. We found a significant surge in approvals since 2018, with clear dominance of the radiology specialty in the application of machine learning tools, attributed to the abundant data from routine clinical data. The study also reveals a reliance on the 510(k)-clearance pathway, emphasizing its basis on substantial equivalence and often bypassing the need for new clinical trials. Also, it notes an underrepresentation of pediatric-focused devices and trials, suggesting an opportunity for expansion in this demographic. Moreover, the geographical limitation of clinical trials, primarily within the United States, points to a need for more globally inclusive trials to encompass diverse patient demographics. This analysis not only maps the current landscape of AI/ML-enabled medical devices but also pinpoints trends, potential gaps, and areas for future exploration, clinical trial practices, and regulatory approaches. In conclusion, our analysis sheds light on the current state of FDA-approved AI/ML-enabled medical devices and prevailing trends, contributing to a wider comprehension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fewer than 30% of AI tools have had their performance and effectiveness thoroughly scrutinized46,47.”
From Preventing unrestricted and unmonitored AI experimentation in healthcare through transparency and accountability (2025) · cites this paper as [47]
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning
Kermany, D. S., Goldbaum, M., Cai, W., Valentim, C. C. S., Liang, H., Baxter, S. L., McKeown, A., Yang, G., Wu, X., Yan, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.010 · Cited by 4,842
Artificial intelligence in radiology
Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H., & Aerts, H. J. W. L. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0016-5 · Cited by 3,803 · cited 1×
“Our analysis serves as a beacon, elucidating the current”
MethodRajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
The future landscape of large language models in medicine
Clusmann, J., Kolbinger, F. R., Muti, H. S., Carrero, Z. I., Eckardt, J.-N., Laleh, N. G., Löffler, C. M. L., Schwarzkopf, S.-C., Unger, M., Veldhuizen, G. P., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00370-1 · Cited by 1,045
A foundation model for generalizable disease detection from retinal images
Zhou, Y., Chia, M. A., Wagner, S. K., Ayhan, M. S., Williamson, D. J., Struyven, R. R., Liu, T., Xu, M., Lozano, M. G., Woodward-Court, P., et al. (2023) · Nature · doi:10.1038/s41586-023-06555-x · Cited by 1,014 · cited 1×
“Our analysis serves as a beacon, elucidating the current”
MethodShifting machine learning for healthcare from development to deployment and from models to data
Zhang, A., Xing, L., Zou, J., & Wu, J. C. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00898-y · Cited by 420 · cited 1×
“Our analysis serves as a beacon, elucidating the current”
MethodGerke, S., Babic, B., Evgeniou, T., & Cohen, I. G. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0262-2 · Cited by 359 · cited 1×
“…of logic, a collection of regulations, or a blueprint) that functions on data input (digitized information) such as lab results, images, symptoms, etc. to generate an outcome that is intended for medical applications to inform, drive, diagnose, treat, etc., as specified by the SaMD producer [12].”
BackgroundReproducibility in machine learning for health research: Still a ways to go
McDermott, M. B. A., Wang, S., Marinsek, N., Ranganath, R., Foschini, L., & Ghassemi, M. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb1655 · Cited by 273 · cited 1×
“The efficacy and robustness of these models are substantially enhanced as they are exposed to more comprehensive, diverse, and heterogeneous data, enabling the models to achieve greater accuracy and reliability in their predictive capabilities [4].”
BackgroundSolving the Explainable AI Conundrum by Bridging Clinicians’ Needs and Developers’ Goals
Bienefeld, N., Boss, J. M., Lüthy, R., Brodbeck, D., Azzati, J., Blaser, M., Willms, J., & Keller, E. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00837-4 · Cited by 159
Cited by
Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice
Khera, R., Oikonomou, E. K., Nadkarni, G. N., Morley, J. R., Wiens, J., Butte, A. J., & Topol, E. J. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.003 · Cited by 264
Machine learning in point-of-care testing: innovations, challenges, and opportunities
Han, G.-R., Goncharov, A., Eryilmaz, M., Ye, S., Palanisamy, B., Ghosh, R., Lisi, F., Rogers, E., Guzman, D., Yigci, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58527-6 · Cited by 239
A Scoping Review of Reporting Gaps in FDA-Approved AI Medical Devices
Muralidharan, V., Adewale, B. A., Huang, C. J., Nta, M. T., Ademiju, P. O., Pathmarajah, P., Hang, M. K., Adesanya, O., Abdullateef, R. O., Babatunde, A. O., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01270-x · Cited by 201
Using Machine Learning to Predict Antimicrobial Resistance―A Literature Review
Sakagianni, A., Koufopoulou, C., Feretzakis, G., Kalles, D., Verykios, V. S., Myrianthefs, P., & Fildisis, G. (2023) · Antibiotics · doi:10.3390/antibiotics12030452 · Cited by 176
Ali, T., Ahmed, S., & Aslam, M. (2023) · Antibiotics · doi:10.3390/antibiotics12030523 · Cited by 170
Metadata
- Authors
- Joshi, G., Jain, A., Araveeti, S. R., Adhikari, S., Garg, H., & Bhandari, M.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- New England College (US)
- Texas A&M University (US)
- Corresponding author
- Bhandari, Mukund
- Venue
- Electronics
- Publisher
- MDPI AG
- Published
- 2024-01-24
- Volume
- 13
- Issue
- 3
- Pages
- 498
- ISSN
- 2079-9292 (ISSN-L)
- OpenAlex
- W4391221083
- Cited by
- 294
- References
- 18
- Citations by year
- 2026: 75 · 2025: 110 · 2024: 88
- FWCI
- 25.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Electronics (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
- Physical Sciences › Computer Science › Information Systems › Internet of Things and AI
- Keywords
- FDA device approval, 510(k) clearance, substantial equivalence, medical device regulation, radiology, diversity in clinical trials, medical device recall
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.